Virulence potential and genome-wide characterization of drug resistant Streptococcus pneumoniae clones selected in vivo by the 7-valent pneumococcal conjugate vaccine.
We used mouse models of pneumococcal colonization and disease combined with full genome sequencing to characterize three major drug resistant clones of S. pneumoniae that were recovered from the nasopharynx of PCV7-immunized children in Portugal. The three clones--serotype 6A (ST2191), serotype 15A...
Guardado en:
Autores principales: | Nelson Frazão, N Luisa Hiller, Evan Powell, Josh Earl, Azad Ahmed, Raquel Sá-Leão, Hermínia de Lencastre, Garth D Ehrlich, Alexander Tomasz |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b5d390fb01c2446680951d62691560dd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Cost-Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine in Seven Chinese Cities
por: Yan Li, et al.
Publicado: (2021) -
A randomized clinical trial of the immunogenicity of 7-valent pneumococcal conjugate vaccine compared to 23-valent polysaccharide vaccine in frail, hospitalized elderly.
por: C Raina Macintyre, et al.
Publicado: (2014) -
Author Correction: Kawasaki Disease following administration of 13-valent pneumococcal conjugate vaccine in young children
por: Chee Fu Yung, et al.
Publicado: (2021) -
Immunogenicity And Safety Of The 13-Valent Pneumococcal Conjugate Vaccine In Patients With Monoclonal Gammopathy Of Undetermined Significance – Relationship With Selected Immune And Clinical Parameters
por: Pasiarski M, et al.
Publicado: (2019) -
High residual carriage of vaccine-serotype Streptococcus pneumoniae after introduction of pneumococcal conjugate vaccine in Malawi
por: Todd D. Swarthout, et al.
Publicado: (2020)